Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
BAJAJHCARE.NS
HoldPremium GrowerBajaj HealthCare Limited · Healthcare · India · $120M · Avg Vol: $414K/d
59
StockRankGet insider-trade alerts
Q
58
V
40
M
55
P/E (TTM)
47.7x
ROE
3.0%
D/E
0.5x
Dividend %
0.3%
COMPANY DESCRIPTION
Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally.
FINANCIAL SUMMARY (INR)
| Year | 2023 | 2024 | 2025 | 2026 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 6.5B | 4.7B | 5.4B | 6.1B | -1.8% | 6.3B |
| EPS (INR) | 15.59 | -30.36 | 13.29 | 4.98 | -31.6% | 7.00 |
| Shares | 27.6M | 27.6M | 31.6M | 33.7M | +22.0% | 33.7M |
| Debt | 4.2B | 3.3B | 2.2B | 2.5B | -15.7% | 2.5B |
| Equity | 3.7B | 2.8B | 4.7B | 5.3B | 13.2% | — |
| Op CF | -221.9M | 922.9M | 216.2M | 580.8M | -20.7% | 580.8M |
| Inv CF | -934.3M | -112.4M | -148.2M | -477.8M | — | — |
| Fin CF | 1.3B | -966.0M | -63.8M | 243.3M | — | — |
Loading 1Y...
PRICE (1Y)+1.9%
SMA 50SMA 200
Close
$3.51
RSI (14)
56.3
52W High
$5.42
From 52W High
0.6%
SCORE BREAKDOWN
Quality
58
ROIC
8.4%65.8
ROE
3.0%50.4
GP/Assets
33.1%68.4
Op. Margin
13.1%70.4
FCF/Assets
1.6%53.2
Piotroski
783.9
Int. Cover
2.4x44.0
D/E Ratio
0.47x30.4
Current Ratio
1.98x38.4
Value
40
P/E (TTM)
47.7x22.8
EV/EBITDA
12.5x58.3
P/FCF
77.2x19.4
P/B
2.0x62.7
P/S
1.8x71.9
Div Yield
0.3%8.2
Momentum
55
52W High %
65%40.5
RS 6M
12%75.2
SMA 50/200
0.97x49.6
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
16%51.7
FUNDAMENTALS
Market Cap
$120M
P/E (Forward)
—
Gross Margin
48.7%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of BAJAJHCARE.NS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| BAJAJHCARE.NS | Bajaj HealthCare Limited(you) | $120M | 59 | Hold |
| THEMISMED.NS | Themis Medicare Limited | $129M | 62 | Hold |
| AMRUTANJAN.NS | Amrutanjan Health Care Limited | $153M | 53 | Hold |
| KILITCH.NS | Kilitch Drugs (India) Limited | $69M | 58 | Hold |
| BAFNAPH.NS | Bafna Pharmaceuticals Limited | $77M | 55 | Hold |
| WANBURY.NS | Wanbury Limited | $91M | 69 | Buy |
| INDOCO.NS | Indoco Remedies Limited | $237M | 57 | Hold |
| ZIMLAB.NS | ZIM Laboratories Limited | $73M | 67 | Buy |
| SIGACHI.NS | Sigachi Industries Limited | $140M | 39 | Hold |
| BETA.NS | Beta Drugs Limited | $228M | 72 | Buy |
Peer medians: ROE 11.9% · P/E 42.5x · Gross margin 59.4%